166 related articles for article (PubMed ID: 10623338)
1. Use of gamma scintigraphy to evaluate the performance of new inhalers.
Newman SP
J Aerosol Med; 1999; 12 Suppl 1():S25-31. PubMed ID: 10623338
[TBL] [Abstract][Full Text] [Related]
2. Preliminary data from phase II studies with Respimat, a propellant-free soft mist inhaler.
Pavia D; Moonen D
J Aerosol Med; 1999; 12 Suppl 1():S33-9. PubMed ID: 10623340
[TBL] [Abstract][Full Text] [Related]
3. Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.
Brand P; Hederer B; Austen G; Dewberry H; Meyer T
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):763-70. PubMed ID: 19281091
[TBL] [Abstract][Full Text] [Related]
4. Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler.
Pitcairn G; Reader S; Pavia D; Newman S
J Aerosol Med; 2005; 18(3):264-72. PubMed ID: 16181001
[TBL] [Abstract][Full Text] [Related]
5. Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicines: comparison of RESPIMAT with conventional metered-dose inhalers with and without spacer devices.
Newman SP; Brown J; Steed KP; Reader SJ; Kladders H
Chest; 1998 Apr; 113(4):957-63. PubMed ID: 9554631
[TBL] [Abstract][Full Text] [Related]
6. A review of the development of Respimat Soft Mist Inhaler.
Dalby R; Spallek M; Voshaar T
Int J Pharm; 2004 Sep; 283(1-2):1-9. PubMed ID: 15363496
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
[TBL] [Abstract][Full Text] [Related]
8. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.
Kässner F; Hodder R; Bateman ED
Drugs; 2004; 64(15):1671-82. PubMed ID: 15257628
[TBL] [Abstract][Full Text] [Related]
9. Reduced Environmental Impact of the Reusable Respimat
Hänsel M; Bambach T; Wachtel H
Adv Ther; 2019 Sep; 36(9):2487-2492. PubMed ID: 31317391
[TBL] [Abstract][Full Text] [Related]
10. Fenoterol delivery by Respimat soft mist inhaler versus CFC metered dose inhaler: cumulative dose-response study in asthma patients.
Vincken W; Dewberry H; Moonen D
J Asthma; 2003 Sep; 40(6):721-30. PubMed ID: 14580004
[TBL] [Abstract][Full Text] [Related]
11. Respimat (a new soft mist inhaler) delivering fenoterol plus ipratropium bromide provides equivalent bronchodilation at half the cumulative dose compared with a conventional metered dose inhaler in asthmatic patients.
Kunkel G; Magnussen H; Bergmann K; Juergens UR; de Mey C; Freund E; Hinzmann R; Beckers B
Respiration; 2000; 67(3):306-14. PubMed ID: 10867600
[TBL] [Abstract][Full Text] [Related]
12. Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica.
Cheng YS; Fu CS; Yazzie D; Zhou Y
J Aerosol Med; 2001; 14(2):255-66. PubMed ID: 11681657
[TBL] [Abstract][Full Text] [Related]
13. Improved delivery of fenoterol plus ipratropium bromide using Respimat compared with a conventional metered dose inhaler.
Goldberg J; Freund E; Beckers B; Hinzmann R
Eur Respir J; 2001 Feb; 17(2):225-32. PubMed ID: 11334124
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat Soft Mist Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma.
von Berg A; Jeena PM; Soemantri PA; Vertruyen A; Schmidt P; Gerken F; Razzouk H
Pediatr Pulmonol; 2004 Mar; 37(3):264-72. PubMed ID: 14966821
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of inhaler devices containing beta(2)-agonist bronchodilators in the treatment of asthma: cochrane systematic review and meta-analysis of more than 100 randomized, controlled trials.
Ram FS
Am J Respir Med; 2003; 2(4):349-65. PubMed ID: 14720001
[TBL] [Abstract][Full Text] [Related]
16. Aerosol physiology, deposition, and metered dose inhalers.
Newman SP
Allergy Proc; 1991; 12(1):41-5. PubMed ID: 2040447
[TBL] [Abstract][Full Text] [Related]
17. Delivery of fenoterol via Respimat, a novel 'soft mist' inhaler. a randomised, double-blind (within device), placebo-controlled, cross-over, dose-ranging study in asthmatic patients.
van Noord JA; Smeets JJ; Creemers JP; Greefhorst LP; Dewberry H; Cornelissen PJ
Respiration; 2000; 67(6):672-8. PubMed ID: 11124651
[TBL] [Abstract][Full Text] [Related]
18.
Wei X; Hindle M; Kaviratna A; Huynh BK; Delvadia RR; Sandell D; Byron PR
J Aerosol Med Pulm Drug Deliv; 2018 Dec; 31(6):358-371. PubMed ID: 29878859
[No Abstract] [Full Text] [Related]
19. Use of Respimat Soft Mist inhaler in COPD patients.
Anderson P
Int J Chron Obstruct Pulmon Dis; 2006; 1(3):251-9. PubMed ID: 18046862
[TBL] [Abstract][Full Text] [Related]
20. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]